PTPN14 is a tyrosine phosphatase attributed in oncogenesis and is mutated in multiple cancer types [49] while NR2C2 is known to protect neuroblastoma cells from chemotherapeutic drugs such as doxorubicin and etoposide [50]. The gene discussed is PTPN14; the disease is neuroblastoma.